CNS (Neoplasia Glioma)

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
[17999840] Health Technol Assess 11(45): iii-iv, ix-221 (2007)

The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma: a rapid and systematic review.
[11359682] Health Technol Assess 5(13): 1-73 (2001)

Targeted therapy in the treatment of malignant gliomas.
[20616900] Onco Targets Ther 2(-): 115-33 (2009)

Epidermal growth factor receptor and mammalian target of rapamycin as therapeutic targets in malignant glioma: current clinical status and perspectives.
[20853178] Target Oncol 5(3): 183-91 (2010)

Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas.
[20844972] Target Oncol 5(3): 193-200 (2010)

Targeted therapies on the horizon for malignant glioma.
[20827575] Target Oncol 5(3): 157-60 (2010)

Vascular endothelial growth factor inhibitors in malignant gliomas.
[20821351] Target Oncol 5(3): 167-74 (2010)

Targeting integrins in malignant glioma.
[20820929] Target Oncol 5(3): 175-81 (2010)

Molecular markers in gliomas: impact for the clinician.
[20809335] Target Oncol 5(3): 201-10 (2010)

Immune therapeutic targeting of glioma cancer stem cells.
[20737294] Target Oncol 5(3): 217-27 (2010)

Glioma stem cells as a target for treatment.
[20737293] Target Oncol 5(3): 211-5 (2010)

MGMT promoter methylation in malignant gliomas.
[20725792] Target Oncol 5(3): 161-5 (2010)

Lessons learned in the development of targeted therapy for malignant gliomas.
[17620423] Mol Cancer Ther 6(7): 1909-19 (2007)

Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456781] Ann Oncol 19 Suppl 2(-): ii83-5 (2008)

Adjuvant treatment of high grade gliomas.
[17018721] Ann Oncol 17 Suppl 10(-): x186-90 (2006)

Radiotherapy in malignant glioma.
[17018720] Ann Oncol 17 Suppl 10(-): x183-5 (2006)

A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma.
[11870527] Br J Cancer 86(4): 501-5 (2002)

Molecularly targeted therapy for malignant glioma.
[17520692] Cancer 110(1): 13-24 (2007)

Temozolomide in the treatment of recurrent malignant glioma.
[14745879] Cancer 100(3): 605-11 (2004)

Low-grade gliomas in adults.
[16794247] Oncologist 11(6): 681-93 (2006)

New treatment strategies for malignant gliomas.
[10394589] Oncologist 4(3): 209-24 (1999)

Angiocentric glioma: a case series.
[19338465] J Neurosurg Pediatr 3(3): 197-202 (2009)

Surgical management of World Health Organization Grade II gliomas in eloquent areas: the necessity of preserving a margin around functional structures.
[20121443] Neurosurg Focus 28(2): E8 (2010)

Embryological development of the human insula and its implications for the spread and resection of insular gliomas.
[19645558] Neurosurg Focus 27(2): E2 (2009)

Management of malignant glioma: steady progress with multimodal approaches.
[16709034] Neurosurg Focus 20(4): E3 (2006)

Pathology of low-grade gliomas: an update of emerging concepts.
[12816723] Neuro Oncol 5(3): 168-78 (2003)

From the archives of the AFIP: superficial gliomas: radiologic-pathologic correlation. Armed Forces Institute of Pathology.
[11706224] Radiographics 21(6): 1533-56 (2001)

Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging.
[16926329] Radiology 240(3): 803-10 (2006)

High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555079] Ann Oncol 21 Suppl 5(-): v190-3 (2010)

Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[19454432] Ann Oncol 20 Suppl 4(-): 126-8 (2009)

Gliomagenesis and the use of neural stem cells in brain tumor treatment.
[20184546] Anticancer Agents Med Chem 10(2): 121-30 (2010)

Epigenetic changes in gliomas.
[18836290] Cancer Biol Ther 7(9): 1326-34 (2008)

Molecular diagnostics of gliomas: state of the art.
[20714900] Acta Neuropathol 120(5): 567-84 (2010)

Protein tyrosine phosphatases in glioma biology.
[19936768] Acta Neuropathol 119(2): 157-75 (2010)

Cerebral gliomas: diffusional kurtosis imaging analysis of microstructural differences.
[20089718] Radiology 254(3): 876-81 (2010)

Mutant metabolic enzymes are at the origin of gliomas.
[19996293] Cancer Res 69(24): 9157-9 (2009)

Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies.
[19951140] Expert Rev Neurother 9(12): 1815-36 (2009)

Insights into the cancer stem cell model of glioma tumorigenesis.
[17549283] Ann Acad Med Singapore 36(5): 352-7 (2007)

The role of surgery in high-grade glioma--is surgical resection justified? A review of the current knowledge.
[17549284] Ann Acad Med Singapore 36(5): 358-63 (2007)

Chemotherapy in adults with gliomas.
[17549285] Ann Acad Med Singapore 36(5): 364-6 (2007)

Molecularly targeted therapies for malignant gliomas.
[19148300] Mol Med 15(3-4): 115-22 (2009)

Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy.
[19192961] Expert Rev Anticancer Ther 9(2): 235-45 (2009)

MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
[15197348] Cancer Biol Ther 3(8): 739-51 (2004)

mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling.
[14508103] Cancer Biol Ther 2(4): 347-53 (2003)

Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
[20523363] Cancer Gene Ther 17(9): 664-74 (2010)

New insights into susceptibility to glioma.
[20212223] Arch Neurol 67(3): 275-8 (2010)

Bevacizumab for malignant gliomas.
[20212225] Arch Neurol 67(3): 285-8 (2010)

Gliadel wafers in the treatment of malignant glioma: a systematic review.
[17938702] Curr Oncol 14(5): 189-94 (2007)

Current concepts and newer developments in the treatment of malignant gliomas.
[19346642] Indian J Cancer 46(2): 88-95 (2009)

Evidence-based adjuvant therapy for gliomas: current concepts and newer developments.
[19346643] Indian J Cancer 46(2): 96-107 (2009)

Current concepts in the pathology and genetics of gliomas.
[19346644] Indian J Cancer 46(2): 108-19 (2009)

Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.
[20368564] J Clin Oncol 28(13): 2293-9 (2010)

Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.
[20445000] CA Cancer J Clin 60(3): 166-93 (2010)

Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression.
[12693889] Ann Intern Med 138(8): 659-68 (2003)

Platelet-derived growth factor receptor alpha in glioma: a bad seed.
[21880180] Chin J Cancer 30(9): 590-602 (2011)

Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.
[20414333] J Oncol 2010(-): 251231 (2010)

Molecular therapeutic targets for glioma angiogenesis.
[20414463] J Oncol 2010(-): 351908 (2010)

Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers.
[20610347] Lancet Neurol 9(7): 717-26 (2010)

Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.
[22084619] Clin Med Insights Oncol 5(-): 265-314 (2011)

Radiotherapeutic alternatives for previously irradiated recurrent gliomas.
[17760992] BMC Cancer 7(-): 167 (2007)

The pathobiology of glioma tumors.
[19737106] Annu Rev Pathol 5(-): 33-50 (2010)

Characterization of invading glioma cells using molecular analysis of leading-edge tissue.
[22102942] J Korean Neurosurg Soc 50(3): 157-65 (2011)

Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis.
[22030012] Herpesviridae 2(1): 10 (2011)

Advances in oncolytic virus therapy for glioma.
[19149710] Recent Pat CNS Drug Discov 4(1): 1-13 (2009)

Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.
[19381449] J Neurooncol 94(3): 299-312 (2009)

Advances in MRI assessment of gliomas and response to anti-VEGF therapy.
[21234719] Curr Neurol Neurosci Rep 11(3): 336-44 (2011)

The functional role of Notch signaling in human gliomas.
[20150387] Neuro Oncol 12(2): 199-211 (2010)

Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab.
[19332770] Neuro Oncol 11(5): 550-5 (2009)

Gene therapy for high-grade glioma.
[20885107] Neurol Med Chir (Tokyo) 50(9): 727-36 (2010)

Pediatric low-grade gliomas.
[19841428] J Child Neurol 24(11): 1397-408 (2009)

Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior.
[21949569] World J Biol Chem 2(9): 193-201 (2011)

Immunotherapeutic approaches for glioma.
[19348609] Crit Rev Immunol 29(1): 1-42 (2009)

Clinical development of experimental therapies for malignant glioma.
[21509204] Sultan Qaboos Univ Med J 11(1): 5-28 (2011)

Current available therapies and future directions in the treatment of malignant gliomas.
[19707392] Biologics 3(-): 15-25 (2009)

GLIOGENE an International Consortium to Understand Familial Glioma.
[17855690] Cancer Epidemiol Biomarkers Prev 16(9): 1730-4 (2007)

Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
[19584260] Mol Cancer Res 7(7): 1000-12 (2009)

DNA repair and resistance of gliomas to chemotherapy and radiotherapy.
[19609002] Mol Cancer Res 7(7): 989-99 (2009)

Glutamate and the biology of gliomas.
[21192095] Glia 59(8): 1181-9 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\CNS (Neoplasia Glioma).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\CNS (Neoplasia Glioma).php on line 92